NYSE: VETVermilion Energy Inc Stock
$13.23-0.16 (-1.19%)
Updated Sep 11, 2026
VET Price
$13.23
Fair Value Price
N/A
Market Cap
$2.02B
52 Week Low
$7.11
52 Week High
$14.82
P/E
-6.39x
P/B
1.31x
P/S
1.09x
PEG
N/A
Dividend Yield
1.49%
Revenue
$1.34B
Earnings
-$314.14M
Gross Margin
62.1%
Operating Margin
-20.12%
Profit Margin
-23.8%
Debt to Equity
1.54
Operating Cash Flow
$648M
Beta
0.94
Next Earnings
Nov 4, 2026
Ex-Dividend
Sep 15, 2026
Next Dividend
Sep 29, 2026
VET Overview
Vermilion Energy Incorporated is a petroleum and natural gas exploration and development company. It owns an 81% working interest in 636,714 acres of developed land and an 85% working interest in 301,026 acres of undeveloped land in Canada, and 130,715 net acres of land in the Powder River basin in the U.S. It also owns s 20% interest in the Corrib natural gas field located off the shore of Ireland. Vermilion Energy was founded in 1994 and is headquartered in Calgary, Alberta.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine VET's potential to beat the market
AStrong Buy
- Stocks with a Zen Rating of Strong Buy (A) had an average return of +28.50% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Oil and Gas
Industry Rating
B
VET
Ranked#1 of 72
Ranked#1 of 72
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.78 | A | |
| $17.68 | A | |
| $1.53 | A |
Be the first to know about important VET news, forecast changes, insider trades & much more!
VET News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VET scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VET is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VET is good value based on its book value relative to its share price (1.31x), compared to the US Oil & Gas E&P industry average (1.85x)
P/B vs Industry Valuation
VET is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more VET due diligence checks available for Premium users.
Valuation
VET price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-6.39x
Industry
15.54x
Market
40.26x
VET price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.31x
Industry
1.85x
VET is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
VET's financial health
Profit margin
Revenue
$365.1M
Net Income
$94.5M
Profit Margin
25.9%
VET's Earnings (EBIT) of -$269.08M... subscribe to Premium to read more.
Interest Coverage Financials
VET's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.9B
Liabilities
$2.3B
Debt to equity
1.54
VET's short-term liabilities ($408.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VET's long-term liabilities ($1.97B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VET's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VET's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$120.2M
Investing
-$79.9M
Financing
$5.8M
VET's operating cash flow ($657.36M)... subscribe to Premium to read more.
Debt Coverage Financials
VET vs Oil and Gas Stocks
Vermilion Energy Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.